TransMedics Group

TransMedics Group

Health Care Equipment & Supplies
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

$3B

Market Cap • 9/14/2026

2018

(8 years)

Founded

2019

(7 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5,7

P/S

4,5

P/EBITDA

25,2

P/OCF

20,4

P/FCF

37,7

P/E

22,1

BVPS

13,1

EPS

3,9

Market Cap

Market Cap

3B

EV

3,4B

EV/Revenue

5

EV/EBITDA

28,6

EV/EBIT

41,3

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,4%

Total Yield

-0,4%

Payout

0%

Retained Earnings

-256M

Profitability

Gross Margin

58,7%

EBITDA Margin

17,7%

EBIT Margin

12,2%

Net Margin

22,7%

D&A/EBITDA

0%

R&D/Revenue

13,8%

Capex/Revenue

10%

Capex/D&A

183,6%

Capex/OCF

45,8%

SBC/OCF

25,4%

% PPE

48%

% Goodwill

0,8%

ROE

36,3%

ROIC

18,6%

Growth

CAGR Revenue 5Y

86,1%

Leverage

N.D./EBITDA

3,3

Debt/Equity

0%

Current Ratio

6,6

Quick Ratio

5,9

Interest Coverage

384,2%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium